PubMed for Bookshelf ID: 4859148

Year	Number of Results
1997	1
1998	7
1999	3
2000	20
2001	13
2002	8
2003	7
2004	4
2005	4
2006	6
2007	5
2008	4
2009	5
2010	6
2011	4
2012	1
2013	1
2014	1
2015	1
2017	1
2018	1
2024	0

1

Editor's Highlight: An Impaired Immune Tolerance Animal Model Distinguishes the Potential of Troglitazone/Pioglitazone and Tolcapone/Entacapone to Cause IDILI.

Mak A, Kato R, Weston K, Hayes A, Uetrecht J. Mak A, et al. Toxicol Sci. 2018 Feb 1;161(2):412-420. doi: 10.1093/toxsci/kfx219. Toxicol Sci. 2018. PMID: 29087505 Free PMC article.

2

Drugs for type 2 diabetes.

[No authors listed] [No authors listed] Med Lett Drugs Ther. 2017 Jan 16;59(1512):9-18. Med Lett Drugs Ther. 2017. PMID: 28076339 Review. No abstract available.

3

Features and Outcomes of 899 Patients With Drug-Induced Liver Injury: The DILIN Prospective Study.

Chalasani N, Bonkovsky HL, Fontana R, Lee W, Stolz A, Talwalkar J, Reddy KR, Watkins PB, Navarro V, Barnhart H, Gu J, Serrano J; United States Drug Induced Liver Injury Network. Chalasani N, et al. Gastroenterology. 2015 Jun;148(7):1340-52.e7. doi: 10.1053/j.gastro.2015.03.006. Epub 2015 Mar 6. Gastroenterology. 2015. PMID: 25754159 Free PMC article.

4

Profile of idiosyncratic drug induced liver injury in Latin America: an analysis of published reports.

Hernández N, Bessone F, Sánchez A, di Pace M, Brahm J, Zapata R, A Chirino R, Dávalos M, Méndez-Sánchez N, Arrese M, Schinoni M, Lucena MI, Andrade RJ. Hernández N, et al. Ann Hepatol. 2014 Mar-Apr;13(2):231-9. Ann Hepatol. 2014. PMID: 24552865 Free article. Review.

5

Incidence, presentation, and outcomes in patients with drug-induced liver injury in the general population of Iceland.

Björnsson ES, Bergmann OM, Björnsson HK, Kvaran RB, Olafsson S. Björnsson ES, et al. Gastroenterology. 2013 Jun;144(7):1419-25, 1425.e1-3; quiz e19-20. doi: 10.1053/j.gastro.2013.02.006. Epub 2013 Feb 16. Gastroenterology. 2013. PMID: 23419359

6

Thiazolidinedione safety.

Kung J, Henry RR. Kung J, et al. Expert Opin Drug Saf. 2012 Jul;11(4):565-79. doi: 10.1517/14740338.2012.691963. Epub 2012 May 22. Expert Opin Drug Saf. 2012. PMID: 22616948 Review.

7

Drugs for type 2 diabetes.

[No authors listed] [No authors listed] Treat Guidel Med Lett. 2011 Aug;9(108):47-54. Treat Guidel Med Lett. 2011. PMID: 21778966 Review. No abstract available.

8

Drug safety of rosiglitazone and pioglitazone in France: a study using the French PharmacoVigilance database.

Berthet S, Olivier P, Montastruc JL, Lapeyre-Mestre M. Berthet S, et al. BMC Clin Pharmacol. 2011 May 24;11:5. doi: 10.1186/1472-6904-11-5. BMC Clin Pharmacol. 2011. PMID: 21609444 Free PMC article.

9

The safety of thiazolidinediones.

Tolman KG. Tolman KG. Expert Opin Drug Saf. 2011 May;10(3):419-28. doi: 10.1517/14740338.2011.534982. Epub 2011 Mar 3. Expert Opin Drug Saf. 2011. PMID: 21366501 Review.

10

Drug-induced idiosyncratic hepatotoxicity: prevention strategy developed after the troglitazone case.

Ikeda T. Ikeda T. Drug Metab Pharmacokinet. 2011;26(1):60-70. doi: 10.2133/dmpk.dmpk-10-rv-090. Epub 2010 Dec 17. Drug Metab Pharmacokinet. 2011. PMID: 21178300 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

100 results

Results by year